The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic

Losurdo, Pasquale; Samardzic, Natasa; Lenarda, Francesca Di; Manzini, Nicoló de; Giudici, Fabiola; Bortul, Marina

doi:10.1007/s13304-021-01212-2

Cited by 9 publications

(30 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An initial 2451 citations were identified for title and abstract screening, of which 77 were eligible for inclusion ( Fig. 1 ) [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] ,…”

Section: Resultsmentioning

confidence: 99%

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

Nickel²,

Ngo³

et al. 2023

The Breast

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

Nickel²,

Ngo³

et al. 2023

The Breast

View full text Add to dashboard Cite

“…The literature search yielded 1,349 potentially eligible records, of which 46 articles were reviewed in full. In addition to our study, 13 studies ( 1 , 12 , 21 – 31 ) published between 2020 and 2022 were included for analysis. The details of the 14 eligible studies are presented in Table 3 .…”

Section: Resultsmentioning

confidence: 99%

“…Ten studies ( 1 , 21 , 22 , 24 – 27 , 29 , 31 ) reported on postoperative mortality. There was no statistically significant difference [OR, 0.90; 95% confidence interval (CI), 0.80, 1.01; p = 0.07] ( Figure 1 ) in the overall incidence of postoperative complications between patients in the COVID-19 pandemic group and those in the pre-COVID-19 pandemic group, with low heterogeneity between studies (I 2 = 26%, p = 0.22).…”

Section: Resultsmentioning

confidence: 99%

Impact of the COVID-19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery: A retrospective study and meta-analysis of data from 11,082 participants

Tang

Pi²,

Tao³

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundThe COVID-19 pandemic is affecting the care of patients with colorectal cancer worldwide, resulting in the postponement of many colorectal cancer surgeries. However, the effectiveness and safety of performing colorectal cancer surgery during the COVID-19 pandemic is unknown. This study evaluated the impact of the COVID−19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery.MethodsWe retrospectively identified patients undergoing colorectal cancer surgery in January 21, 2019, to April 1, 2019, vs. January 21, 2020, to April 1, 2020. Data regarding perioperative outcomes (postoperative complications, conversion rate, duration of surgery, intraoperative blood loss, transfusion, reoperation, intensive care, histological examination, morbidity, and length of hospital stay) were retrieved and compared between the two cohorts. A meta-analysis of 14 studies was also conducted to assess the impact of the COVID−19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery.ResultsThe sample included 68 patients who underwent surgery in 2020 and 136 patients who underwent surgery in 2019. No patient was converted from laparoscopy to laparotomy or required reoperation. R0 resection was completed in all patients in both groups. There was no significant difference in postoperative complications (p = 0.508), duration of surgery (p = 0.519), intraoperative blood loss (p = 0.148), transfusion (0.217), intensive care (p = 0.379), mean lymph node yield (p = 0.205), vascular positivity rate (p = 0.273), nerve invasion rate (p = 0.713), anastomosis leak rate (p = 1), morbidity (p = 0.478), and length of hospital stay (p = 0.623) between the two groups. The meta-analysis also showed no significant difference in short-term outcomes between the two groups.ConclusionsOur study shows that the COVID-19 pandemic has not led to a deterioration in the surgical outcomes of colorectal cancer surgery or reduction in the quality of cancer removal. Therefore, we do not recommend postponing elective colorectal cancer surgery during the COVID-19 pandemic.

show abstract

“…on CRC screening differs by country 14 , which may be due to the stringency of lockdown policies by country, among other factors. In Korea, it was reported that there was no CRC stage upshifting during the COVID-19 pandemic in the early days of the pandemic 15 .…”

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 99%

“…much evidence has already been reported worldwide of the negative impacts of the pandemic on cancer diagnosis and treatment 4,13,14,22 . Because cancer patients tend to travel to other areas for the purpose of cancer treatment 23 , the damage caused by movement restrictions or social distancing during the pandemic period will be larger than other diseases.…”

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 99%

No evidence of delay in colorectal cancer diagnosis during the COVID-19 pandemic in Gwangju and Jeonnam, Korea

Kim

Kang

et al. 2022

Epidemiol Health

View full text Add to dashboard Cite

Purpose: We evaluated whether the coronavirus-2019 (COVID-19) pandemic caused delays in diagnosis and treatment of colorectal cancer (CRC) in Korea, where there have been no regional or hospital lockdowns during the pandemic period. Method: Data on CRC patients (n = 1,445) diagnosed in the Gwangju metropolitan city and Jeonnam province between January 2019 and December 2021 were assessed. Stage at the time of CRC diagnosis, route to diagnosis, time to initial cancer treatment, and length of hospital admission were compared before and during the COVID-19 pandemic. Logistic regression was also performed to identify the factors associated with the risk for diagnosis in an advanced stage. Results: No negative effects indicating a down-shifting of CRC stage at diagnosis and delayed treatment during the pandemic were observed. Instead, the risk for advanced stage at diagnosis (TNM stage III/IV) was reduced in CRC patients diagnosed during the pandemic (odds ratio 0.768, 95% confidence interval 0.647-0.911). No significant differences in the interval from diagnosis to operation or chemotherapy were observed. Conclusion: No negative effects on CRC diagnosis and treatment were found until the of the 2021, which may be related to the small magnitude of the COVID-19 epidemic, absence of a lockdown policy in Korea, and rebounding increase of diagnostic colonoscopy in 2021.

show abstract

The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic

Cited by 9 publications

References 25 publications

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

Impact of the COVID-19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery: A retrospective study and meta-analysis of data from 11,082 participants

No evidence of delay in colorectal cancer diagnosis during the COVID-19 pandemic in Gwangju and Jeonnam, Korea

Contact Info

Product

Resources

About